Literature DB >> 9303356

Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations.

S Masunaga1, K Ono, M Akaboshi, Y Nishimura, M Suzuki, Y Kinashi, M Takagaki, M Hiraoka, M Abe.   

Abstract

C3H/He mice bearing SCC VII tumours received 5-bromo-2'-deoxyuridine (BrdU) continuously for 5 days via implanted mini-osmotic pumps in order to label all proliferating (P) cells. The tumours were then heated at 40 degrees C for 60 min. At various time points after heating, tumour-bearing mice were irradiated while alive or after being killed. Immediately after irradiation, the tumours were excised, minced and trypsinized. The tumour cell suspensions obtained were incubated with cytochalasin-B (a cytokinesis blocker), and the micronucleus (MN) frequency in cells without BrdU labelling, which could be regarded as quiescent (Q) cells, was determined using immunofluorescence staining for BrdU. The MN frequency in the total (P+Q) tumour cell population was determined from the irradiated tumours that were not pretreated with BrdU. The MN frequency of BrdU unlabelled cells was then used to calculate the surviving fraction of the unlabelled cells from the regression line for the relationship between the MN frequency and the surviving fraction of total (P+Q) tumour cells. In general, Q cells contained a greater hypoxic fraction (HF) than the total tumour cell population. Mild heating decreased the HF of Q cells more markedly than in the total cell population, and the minimum values of HFs of both total and Q cell populations were obtained 6 h after heating. Two days after heating, the HF of total tumour cells returned to almost that of unheated tumours. In contrast, the HF of Q cells did not return to the HF level of unheated tumours until 1 week after heating. It was thought that irradiation within 12 h after mild heating might be a potentially promising therapeutic modality for controlling radioresistant Q tumour cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303356      PMCID: PMC2228014          DOI: 10.1038/bjc.1997.430

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Tumour oxygenation is increased by hyperthermia at mild temperatures.

Authors:  C W Song; A Shakil; J L Osborn; K Iwata
Journal:  Int J Hyperthermia       Date:  1996 May-Jun       Impact factor: 3.914

2.  The correlation between cell survival curve and dose response curve of micronucleus (MN) frequency.

Authors:  K Ono; E Wandl; K Tsutsui; K Sasai; M Abe
Journal:  Strahlenther Onkol       Date:  1989-11       Impact factor: 3.621

Review 3.  Important prognostic factors influencing outcome of combined radiation and hyperthermia.

Authors:  R Valdagni; F F Liu; D S Kapp
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-10       Impact factor: 7.038

Review 4.  Sensitization of hypoxic tumour cells--clinical experience.

Authors:  J Overgaard
Journal:  Int J Radiat Biol       Date:  1989-11       Impact factor: 2.694

5.  Regrowth and radiation sensitivity of quiescent cells isolated from EMT6/Ro-fed plateau monolayers.

Authors:  C K Luk; P C Keng; R M Sutherland
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

6.  Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR.

Authors:  J B Mitchell; G Morstyn; A Russo; T J Kinsella; A Fornace; S McPherson; E Glatstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-08       Impact factor: 7.038

7.  Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation.

Authors:  J M Brown
Journal:  Br J Radiol       Date:  1979-08       Impact factor: 3.039

8.  The problem of the quiescent cancer cell.

Authors:  R C Jackson
Journal:  Adv Enzyme Regul       Date:  1989

Review 9.  Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity.

Authors:  C N Coleman
Journal:  J Natl Cancer Inst       Date:  1988-05-04       Impact factor: 13.506

10.  Microangiographic and histologic analysis of the effects of hyperthermia on murine tumor vasculature.

Authors:  Y Nishimura; M Hiraoka; S Jo; K Akuta; Y Yukawa; Y Shibamoto; M Takahashi; M Abe
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-08       Impact factor: 7.038

View more
  6 in total

1.  Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations.

Authors:  S Masunaga; Y Matsumoto; G Kashino; R Hirayama; Y Liu; H Tanaka; Y Sakurai; M Suzuki; Y Kinashi; A Maruhashi; K Ono
Journal:  Br J Radiol       Date:  2010-09       Impact factor: 3.039

2.  Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.

Authors:  Shin-Ichiro Masunaga; Hideko Nagasawa; Keiko Gotoh; Yoshinori Sakurai; Yoshihiro Uto; Hitoshi Hori; Kenji Nagata; Minoru Suzuki; Akira Maruhashi; Yuko Kinashi; Koji Ono
Journal:  Radiat Med       Date:  2006-02

3.  Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.

Authors:  Shin-Ichiro Masunaga; Koji Ono; Mitsunori Kirihata; Masao Takagaki; Yoshinori Sakurai; Yuko Kinashi; Tooru Kobayashi; Minoru Suzuki; Kenji Nagata; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori
Journal:  J Cancer Res Clin Oncol       Date:  2003-01-11       Impact factor: 4.553

4.  Significance of manipulating intratumor hypoxia in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumor quiescent cells.

Authors:  Shin-ichiro Masunaga; Yoshitaka Matsumoto; Ryoichi Hirayama; Genro Kashino; Hiroki Tanaka; Minoru Suzuki; Yuko Kinashi; Yong Liu; Koichi Ando; Koji Ono
Journal:  Clin Exp Metastasis       Date:  2009-05-23       Impact factor: 5.150

5.  Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.

Authors:  S I Masunaga; K Ono; M Kirihata; M Takagaki; Y Sakurai; Y Kinashi; T Kobayashi; H Nagasawa; Y Uto; H Hori
Journal:  Jpn J Cancer Res       Date:  2001-09

6.  An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness.

Authors:  Shin-Ichiro Masunaga; Yu Sanada; Keizo Tano; Yoshinori Sakurai; Hiroki Tanaka; Takushi Takata; Minoru Suzuki; Koji Ono
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.